
ATYR PHARMA INC
ATYR · NASDAQ
Updated at 2026-10-14 09:27:48
- Today's High
- $0.22
- Today’s Low
- $0.20
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.24
- Previous Close
- $0.21
- Volume
- 2.02M
- Market Cap
- $21.06M
- P/E Ratio
- --
- EPS
- $-0.79
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 10240 SORRENTO VALLEY ROAD, SAN DIEGO, CA, UNITED STATES, 92121
- Country
- US
- Listing Date
- 2015-05-07
- Fiscal Year End
- December
- Shares Outstanding
- 98.05M
- CIK
- 0001339970
- Website
- www.atyrpharma.com
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company is headquartered in San Diego, California.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$190K
Operating Expenses
2026-06-30
$10.47M
2026-03-31
$11.04M
2025-12-31
$14.79M
2025-09-30
$4.8M
Net Income
2026-06-30
-$10.3M
2026-03-31
-$10.79M
2025-12-31
-$13.96M
2025-09-30
-$25.74M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
-13.54K%
Earnings Per Share
2026-06-30
$-0.11
2026-03-31
$-0.11
2025-12-31
$-0.14
2025-09-30
$-0.26
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$10.47M
2026-03-31
-$10.39M
2025-12-31
-$13.57M
2025-09-30
-$25.35M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $190K |
| Operating Expenses | $10.47M | $11.04M | $14.79M | $4.8M |
| Net Income | -$10.3M | -$10.79M | -$13.96M | -$25.74M |
| Net Profit Margin | -- | -- | -- | -13.54K% |
| Earnings Per Share | $-0.11 | $-0.11 | $-0.14 | $-0.26 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$10.47M | -$10.39M | -$13.57M | -$25.35M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.